Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miquel Salvà
Observed names:
M Salva,
M. Salva,
Miquel SALVA,
Miquel Salva
Institution:
Almirall (Spain)
Observed institutions:
Universitat Autònoma de Barcelona,
Almirall (Spain),
Hospital Universitario Ramón y Cajal
OpenAlex ID:
A5083000340
Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: In vitro plasma inactivation and pharmacological activity of its main metabolites
2010
·
Sonia Sentellas
, Israel Ramos
, et al.
·
European Journal of Pharmaceutical Sciences
·
71
Purification and properties of five different forms of human procarboxypeptidases
1989
·
Roger PASCUAL
, Francisco J. BURGOS
, et al.
·
European Journal of Biochemistry
·
69
Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment
1991
·
Francisco J. Burgos
, Miquel Salva
, et al.
·
Biochemistry
·
53
Identification of the Human Liver Enzymes Involved in the Metabolism of the Antimigraine Agent Almotriptan
2003
·
Miquel Salva
, Josep M. Jansat
, et al.
·
Drug Metabolism and Disposition
·
50
Identification of the Human Enzymes Responsible for the Enzymatic Hydrolysis of Aclidinium Bromide
2010
·
Joan Albertí
, Audrey Martinet
, et al.
·
Drug Metabolism and Disposition
·
38
The Prokinetic Cinitapride Has No Clinically Relevant Pharmacokinetic Interaction and Effect on QT during Coadministration with Ketoconazole
2007
·
Marta Robert
, Miquel Salvà
, et al.
·
Drug Metabolism and Disposition
·
26
No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P‐glycoprotein (P‐gp) drug transporter
2019
·
Jordi Aubets
, Josep‐Maria Jansat
, et al.
·
Pharmacology Research & Perspectives
·
23
PDF
Pharmacokinetics and safety of oral almotriptan in healthy male volunteers
2004
·
J. McEwen
, M. Salva
, et al.
·
Biopharmaceutics & Drug Disposition
·
14
Development of a UHPLC method for the assessment of the metabolic profile of cinitapride
2011
·
Helena Marquez
, Joan Albertí
, et al.
·
Journal of Separation Science
·
12
In vitro liver metabolism of aclidinium bromide in preclinical animal species and humans: Identification of the human enzymes involved in its oxidative metabolism
2010
·
Joan J. Albertí
, Sònia Sentellas
, et al.
·
Biochemical Pharmacology
·
12
Disposition and metabolism of almotriptan in rats, dogs and monkeys
2006
·
J. Aubets
, A. Cardenas
, et al.
·
Xenobiotica
·
11
Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers
2006
·
X. Cabarrocas
, M. Salva
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
8
Characterization of in vitro metabolic profiles of cinitapride obtained with liver microsomes of humans and various mammal species using UHPLC and chemometric methods for data analysis
2012
·
Helena Marquez
, Joan Albertí
, et al.
·
Analytical and Bioanalytical Chemistry
·
4
Enzymatic Hydrolysis of Aclidinium Bromide in Human Plasma by Human Esterases.
2009
·
J Alberti
, A Martinet
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Improvements in the application of the 4,4-N,N-Dimethylaminoazobenzene-4′-isothiocyanate micromethod to the sequence analysis of proteins
1989
·
Miquel Salvà
, Francesc X. Avilés
·
Analytical Biochemistry
·
2
Nuevos retos en la evaluación preclínica de la toxicidad de medicamentos
2001
·
Miquel Salvà
, Ana Gloria Gil
, et al.
·
Redalyc (Universidad Autónoma del Estado de México)
Show more works
View as search
Works count:
16
Citation count:
395
H-index:
11
I10-index:
11
Year
Topic
Type